UK free cancer drug Rxs decision welcomed by the RPSGB

Responding to the abolition of prescription charges for cancer patients in England announced January 20, Howard Duff, director of England at the  Royal Pharmaceutical Society of Great Britain said: "this decision is  excellent news for patients with cancer and we welcome it  wholeheartedly. Pharmacists see the financial hardship that can be  caused by prescription charges on a daily basis and we urge patients to  register for their exemption certificate as soon as possible."

He continued: "we also welcome the news that the scheme will be extended  to include all patients with long-term conditions. It's vital the  financial barrier of prescription charges should be lifted for them.  There are already a number of discrepancies in the current system of  prescription charges which is widely understood to be both illogical and  unfair. The Society would like to see the current review widened beyond  just long-term conditions to create a simpler and fairer system for  all."